Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study

MLA

Nahid Beladi Moghadam, et al. “Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study.” Current Stem Cell Research & Therapy, vol. 7, Dec. 2012, pp. 407–14. EBSCOhost, https://doi.org/10.2174/157488812804484648.

APA

Nahid Beladi Moghadam, Katayoun Alikhani, Jamshid Lotfi, Saeideh Khorramnia, Sirous Jafarian, Samira Yadegari, Mohammad Reza Gheini, Sanaz Ahmadi Karvigh, Behrouz Nikbin, Mohammad Reza Motamed, Mansoureh Togha, Mohammad Ali Sahraian, Mohammad Hossien Harirchian, Aida Aghsaie, Mandana Mohyeddin Bonab, & Seyed Massoud Hosseinian. (2012). Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study. Current Stem Cell Research & Therapy, 7, 407–414. https://doi.org/10.2174/157488812804484648

Chicago

Nahid Beladi Moghadam, Katayoun Alikhani, Jamshid Lotfi, Saeideh Khorramnia, Sirous Jafarian, Samira Yadegari, Mohammad Reza Gheini, et al. 2012. “Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study.” Current Stem Cell Research & Therapy 7 (December): 407–14. doi:10.2174/157488812804484648.